19th International Conference on Pharmaceutical Testing and Adverse Effects
|19th International Conference on Pharmaceutical Testing and Adverse Effects|
|Date||August 7 - 8, 2017|
|Place||New York, USA|
The ICPTAE 2017: 19th International Conference on Pharmaceutical Testing and Adverse Effects aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmaceutical Testing and Adverse Effects. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmaceutical Testing and Adverse Effects.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmaceutical Testing and Adverse Effects are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index, and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk.
Special Journal Issues
ICPTAE 2017 has teamed up with the Special Journal Issue on Pharmaceutical Testing and Adverse Effects. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
|Abstracts/Full-Text Paper Submission Deadline||June 15, 2017|
|Notification of Acceptance/Rejection||June 30, 2017|
|Final Paper Submission & Early Bird Registration Deadline||July 7, 2017|
|Conference Dates||August 7 - 8, 2017|
Conference Registration Fees
Author Conference Registration includes Paper Presentation, Proceedings Volume Part (where your paper is published), Proceedings CD, Attendance to all Sessions, Conference Programme, Name Tag, Luncheons and Coffee Breaks, Certificate of Attendance and Presentation, and Small Handbag.
Listener Conference Registration includes Attendance to All Sessions, Proceedings CD, Conference Programme, Name Tag, Luncheons and Coffee Breaks, Certificate of Attendance and Small Handbag.
Early Bird Registration
Early Bird registration is valid until 2017-07-07 23:59:59.
|Participation Type||Early Registration Fees||Registration Fees|
|Non-Student Oral/Poster Presenter Registration||450 €||500 €|
|Student Oral/Poster Presenter Registration||350 €||400 €|
|Listener Registration||250 €||300 €|
|Local participation||login to see||login to see|
|Additional Paper Publication||100 €|
|Extra Proceedings Book||50 €|
Selected Conference Papers
1)21st Century Biotechnological Research and Development Advancements for Industrial Development in India
2)Patient Support Program in Pharmacovigilance: Foster Patient Confidence and Compliance
Atul Khurana, Rajul Rastogi, Hans-Joachim Gamperl
3)Management Software for the Elaboration of an Electronic File in the Pharmaceutical Industry Following Mexican Regulations
M. Peña Aguilar Juan, Ríos Hernández Ezequiel, R. Valencia Luis
4)Polydopamine Nanoparticle as a Stable and Capacious Nano-Reservoir of Rifampicin
Tasnuva Tamanna, Aimin Yu
5)Determinants of Profitability in Indian Pharmaceutical Firms in the New Intellectual Property Rights Regime
Shilpi Tyagi, D. K. Nauriyal
6)Quality Based Approach for Efficient Biologics Manufacturing
Takashi Kaminagayoshi, Shigeyuki Haruyama
7)Controlled Release of Glucosamine from Pluronic-Based Hydrogels for the Treatment of Osteoarthritis
Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
8)Use of Curcumin in Radiochemotherapy Induced Oral Mucositis Patients: A Control Trial Study
9)Learners’ Violent Behaviour and Drug Abuse as Major Causes of Tobephobia in Schools
10)The Effect of a Three-Month Training Program on the Back Kyphosis of Former Male Addicts
M. J. Pourvaghar, Sh. Khoshemehry
11)Speciation, Preconcentration, and Determination of Iron(II) and (III) Using 1,10-Phenanthroline Immobilized on Alumina-Coated Magnetite Nanoparticles as a Solid Phase Extraction Sorbent in Pharmaceutical Products
Hossein Tavallali, Mohammad Ali Karimi, Gohar Deilamy-Rad
12)Radiochemical Purity of 68Ga-BCA-Peptides: Separation of All 68Ga Species with a Single iTLC Strip
Anton A. Larenkov, Alesya Ya Maruk
13)Treatment of Mycotic Dermatitis in Domestic Animals with Poly Herbal Drug
U. Umadevi, T. Umakanthan
14)Identifying a Drug Addict Person Using Artificial Neural Networks
Mustafa Al Sukar, Azzam Sleit, Abdullatif Abu-Dalhoum, Bassam Al-Kasasbeh
15)Co-payment Strategies for Chronic Medications: A Qualitative and Comparative Analysis at European Level
Pedro M. Abreu, Bruno R. Mendes